| Li, Jian |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
NCT05525637: Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder |
|
|
| Recruiting | 3 | 1041 | RoW | YZJ-1139 20mg, YZJ-1139 40mg, Placebo | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Insomnia Disorder | 12/24 | 12/24 | | |
nAMD, NCT05461339: TAB014 Compared to Lucentis® in Patients with Neovascular Age-related Macular Degeneration |
|
|
| Active, not recruiting | 3 | 488 | RoW | TAB014 Monoclonal Antibody Injection, TAB014, Ranibizumab Injection [Lucentis], Lucentis | TOT Biopharm Co., Ltd., Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. | Neovascular Age-related Macular Degeneration | 09/24 | 02/25 | | |
NCT06292013: A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) |
|
|
| Recruiting | 3 | 12500 | Europe, Canada, Japan, US, RoW | Lepodisiran Sodium, LY3819469, Placebo | Eli Lilly and Company | Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a) | 03/29 | 03/29 | | |
| Recruiting | 3 | 240 | RoW | Equecabtagene Autoleucel Injection, FUCASO, Daratumumab, Pomalidomide, Bortezomib, Dexamethasone | Nanjing IASO Biotechnology Co., Ltd. | Multiple Myeloma | 08/27 | 12/30 | | |
NCT05262010: A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years |
|
|
| Recruiting | 3 | 13500 | RoW | 11-valent recombinant human papilloma virus vaccine (Hansenula polymorpha), placebo | National Vaccine and Serum Institute, China, Chengdu Institute of Biological Products Co.,Ltd., Simoon Record Pharma Information Consulting Co., Ltd., Beijing Kantorico Statistical Technology Co., Ltd., Guangxi Center for Disease Control and Prevention, Hunan Provincial Center for Disease Control and Prevention, Sichuan Center for Disease Control and Prevention, Shanxi Center for Disease Control and Prevention | HPV InfectioN, HPV-Related Carcinoma | 06/28 | 06/28 | | |
NCT05345522: A Study of Anti-IL-6R mAb Injection in Patients With iMCD |
|
|
| Recruiting | 2 | 9 | RoW | Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg, Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 6mg/kg, Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 8mg/kg | Beijing VDJBio Co., LTD. | Idiopathic Multicentric Castleman's Disease | 11/22 | 12/24 | | |
NCT04474938: Daratumumab Combined With Bortezomib and Dexamethasone in Mayo 04 Stage III Light Chain Amyloidosis |
|
|
| Active, not recruiting | 2 | 40 | RoW | Daratumumab, Bortezomib, Dexamethasone | Peking Union Medical College Hospital, Xian-Janssen Pharmaceutical Ltd. | Amyloidosis; Systemic | 06/23 | 03/24 | | |
NCT04716634: Efficacy and Safety of Tislelizumab in Combination With Fruquintinib in Participants With Selected Solid Tumors |
|
|
| Completed | 2 | 84 | RoW | Tislelizumab, BGB-A317, Fruquintinib, HMPL-013 | BeiGene, Hutchison Medipharma Limited | Advanced Solid Tumors | 02/24 | 02/24 | | |
NCT05092815: The Efficacy and Safety of HLX208 in Adult Langerhans Cell Histiocytosis (LCH) and Erdheim-Chester Disease (ECD) With BRAF V600E Mutation |
|
|
| Active, not recruiting | 2 | 25 | RoW | HLX208, BRAF V600E inhibitor | Shanghai Henlius Biotech | Langerhans Cell Histiocytosis, Erdheim-Chester Disease, LCH, ECD | 06/24 | 10/24 | | |
| Recruiting | 1/2 | 29 | RoW | KQ-2003 CAR T-cells | Novatim Immune Therapeutics (Zhejiang) Co., Ltd. | Multiple Myeloma | 03/26 | 03/26 | | |
NCT06526819: SMP-3124LP in Adults With Advanced Solid Tumors |
|
|
| Recruiting | 1/2 | 120 | Japan, US | SMP3124LP | Sumitomo Pharma America, Inc. | Solid Tumor | 12/28 | 05/29 | | |
NCT03692663: Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer |
|
|
| Recruiting | 1 | 9 | RoW | TABP EIC, Cyclophosphamide, fludarabine | Allife Medical Science and Technology Co., Ltd., Tianjin People's Hospital | Metastatic Castration-resistant Prostate Cancer | 06/23 | 06/24 | | |
| Recruiting | 1 | 132 | Japan, RoW | SHR-A2009 | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Advanced Solid Tumors | 12/23 | 12/24 | | |
NCT06518876: A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory POEMS Syndrome |
|
|
| Not yet recruiting | 1 | 21 | RoW | KQ-2003 CAR T-cells | Novatim Immune Therapeutics (Zhejiang) Co., Ltd. | POEMS Syndrome | 12/27 | 12/27 | | |
NCT05023551: Study of DSP-0390 in Patients with Recurrent High-Grade Glioma |
|
|
| Active, not recruiting | 1 | 39 | Japan, US | DSP-0390 | Sumitomo Pharma America, Inc. | High Grade Glioma, Glioblastoma Multiforme | 09/26 | 10/26 | | |
| Active, not recruiting | 1 | 31 | US | TP-1454 monotherapy | Sumitomo Pharma America, Inc. | Advanced Solid Tumor, Anal Cancer | 03/25 | 05/25 | | |
NCT05227378: Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer |
|
|
| Not yet recruiting | N/A | 36 | RoW | neoantigen tumor vaccine with or without PD-1/L1 | Shen Lin, NeoCura | Gastric Cancer | 03/25 | 08/25 | | |
